Epigenetics of Indolent Lymphoma and How It Drives Novel Therapeutic Approaches—Focus on EZH2-Targeted Drugs
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1534-6269
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Epigenetics of Indolent Lymphoma and How It Drives Novel Therapeutic Approaches—Focus on EZH2-Targeted Drugs ; volume:23 ; number:7 ; day:3 ; month:5 ; year:2021 ; pages:1-7 ; date:7.2021
Current oncology reports ; 23, Heft 7 (3.5.2021), 1-7, 7.2021
- Creator
-
Longley, Jemma
Johnson, Peter W. M.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s11912-021-01076-0
- URN
-
urn:nbn:de:101:1-2021101123040553414766
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:22 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Longley, Jemma
- Johnson, Peter W. M.
- SpringerLink (Online service)
Other Objects (12)
Targeting epigenetics in sarcomas through EZH2 inhibition
Translating epigenetics into clinic: focus on lupus
The role of epigenetics in T-cell lymphoma
Epigenetics-targeted drugs: current paradigms and future challenges
Targeted therapy in lymphoma
The pharmaco-epigenetics of hypertension: a focus on microRNA
Epigenetics
EZH2 K63-polyubiquitination affecting migration in extranodal natural killer/T-cell lymphoma
Epigenetics & chromatin
Epigenetics communications
Clinical epigenetics
EZH2-mediated PP2A inactivation confers resistance to HER2-targeted breast cancer therapy
Targeting epigenetics in sarcomas through EZH2 inhibition
Translating epigenetics into clinic: focus on lupus
The role of epigenetics in T-cell lymphoma
Epigenetics-targeted drugs: current paradigms and future challenges
Targeted therapy in lymphoma
The pharmaco-epigenetics of hypertension: a focus on microRNA
Epigenetics
EZH2 K63-polyubiquitination affecting migration in extranodal natural killer/T-cell lymphoma
Epigenetics & chromatin
Epigenetics communications
Clinical epigenetics
EZH2-mediated PP2A inactivation confers resistance to HER2-targeted breast cancer therapy
Targeting epigenetics in sarcomas through EZH2 inhibition
Translating epigenetics into clinic: focus on lupus
The role of epigenetics in T-cell lymphoma
Epigenetics-targeted drugs: current paradigms and future challenges
Targeted therapy in lymphoma
The pharmaco-epigenetics of hypertension: a focus on microRNA
Epigenetics
EZH2 K63-polyubiquitination affecting migration in extranodal natural killer/T-cell lymphoma
Epigenetics & chromatin
Epigenetics communications
Clinical epigenetics